Platelet 5-HT receptor binding during depressive illness and tricyclic antidepressant treatment
- PMID: 2959699
- DOI: 10.1016/0165-0327(87)90072-3
Platelet 5-HT receptor binding during depressive illness and tricyclic antidepressant treatment
Abstract
5-Hydroxytryptamine (5-HT) receptor binding was determined in intact human platelets using 125I-iodolysergic acid diethylamide (125I-iodoLSD). The assay revealed that platelets possess a single population of specific binding sites for 125I-iodoLSD which have a high affinity for the 5-HT2 receptor antagonists, ketanserin and spiperone. There was no difference in platelet 125I-iodoLSD receptor binding between depressed patients and controls. However, treatment with tricyclic antidepressants increased the number of 125I-iodoLSD receptor binding sites without significantly altering their affinity.
Similar articles
-
Comparison of [125I]iodolysergic acid diethylamide binding in human frontal cortex and platelet tissue.J Neurochem. 1989 Jul;53(1):191-6. doi: 10.1111/j.1471-4159.1989.tb07313.x. J Neurochem. 1989. PMID: 2723656
-
5-Hydroxytryptamine (5-HT)-induced shape change in human platelets determined by computerized data acquisition: correlation with [125I]-iodoLSD binding at 5-HT2 receptors.Blood Coagul Fibrinolysis. 1991 Feb;2(1):17-24. doi: 10.1097/00001721-199102000-00003. Blood Coagul Fibrinolysis. 1991. PMID: 1772986
-
Serotonergic and adrenergic regulation of skeletal muscle metabolism in the rat. II. The use of [125I]iodolysergic acid diethylamide and [125I]iodopindolol as probes of sarcolemmal receptor function and specificity.J Biol Chem. 1983 Oct 25;258(20):12499-508. J Biol Chem. 1983. PMID: 6313663
-
[Review of findings on binding of tricyclic antidepressants].Cesk Psychiatr. 1993 Apr;89(2):71-8. Cesk Psychiatr. 1993. PMID: 8403025 Review. Czech.
-
Human platelet 5-hydroxytryptamine receptors: binding of [3H]-lysergic acid diethylamide (LSD). Effects of chronic neuroleptic and antidepressant drug administration.Experientia. 1988 Feb 15;44(2):142-5. doi: 10.1007/BF01952198. Experientia. 1988. PMID: 2894321 Review.
Cited by
-
Serotonin-induced platelet intracellular calcium mobilization in depressed patients.Psychopharmacology (Berl). 1994 Jan;113(3-4):322-7. doi: 10.1007/BF02245204. Psychopharmacology (Berl). 1994. PMID: 7862840 Clinical Trial.
-
Phosphoinositide system-linked serotonin receptor subtypes and their pharmacological properties and clinical correlates.J Psychiatry Neurosci. 1995 May;20(3):215-25. J Psychiatry Neurosci. 1995. PMID: 7786883 Free PMC article. Review.
-
5-HT(2A) receptor binding is reduced in drug-naive and unchanged in SSRI-responder depressed patients compared to healthy controls: a PET study.Psychopharmacology (Berl). 2003 Apr;167(1):72-8. doi: 10.1007/s00213-002-1379-5. Epub 2003 Mar 11. Psychopharmacology (Berl). 2003. PMID: 12632246
-
Tandem regulation of phosphoinositide signaling and acute behavioral effects induced by antidepressant agents in rats.Psychopharmacology (Berl). 2007 Aug;193(2):271-82. doi: 10.1007/s00213-007-0784-1. Epub 2007 Apr 15. Psychopharmacology (Berl). 2007. PMID: 17435992
-
Serotonin but not norepinephrine-induced calcium mobilization of platelets is enhanced in affective disorders.Psychopharmacology (Berl). 1992;106(3):311-4. doi: 10.1007/BF02245410. Psychopharmacology (Berl). 1992. PMID: 1570376
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources